Industrial biotech a $115B industry: report

August 25, 2011 |

In Washington state, Rob Carlson, in his Biodesic 2011 Bioeconomy Update, writes that “total 2010 revenues from genetically modified products exceeded $300 billion, or the equivalent of more than 2% of Gross Domestic Product (GDP).”

Addressing biofuels, chemicals and materials, he added, “Extending prior revenue figures in the sub-sector, I estimate that 2010 U.S. revenues from industrial biotechnology were at least $115 billion. Revenues are likely to climb sharply starting in 2011 with the market introduction of chemicals, fuels, and co-products such as cosmetics from firms such as Solazyme, Gevo, and Amyris.”

Category: Producer News

Comments are closed.